2024
DOI: 10.1039/d3cp05934k
|View full text |Cite
|
Sign up to set email alerts
|

Can Duvelisib and Eganelisib work for both cancer and COVID-19? Molecular-level insights from MD simulations and enhanced samplings

Saroj Kumar Panda,
Shaswata Karmakar,
Parth Sarthi Sen Gupta
et al.

Abstract: SARS-CoV-2 has caused severity and anxiety worldwide, evolving into more dreadful variants capable of infringing the host's immunity. Cytokine storms, led by PI3Kš›¾, are common in cancer and SARS-CoV-2. Naturally,...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 64 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?